ReviewFrontiers in cellular neuroscience2026
Gut-brain axis mechanisms of remote brain dysfunction after traumatic spinal cord injury: immune inflammation, the vagus nerve, and neuroendocrine pathways.
Review in Frontiers in cellular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic spinal cord injury (SCI) has traditionally been regarded as a central nervous system injury mainly confined to the injured segment. However, increasing evidence indicates that SCI can also induce neuroinflammation, cognitive decline, and emotional disorders in remote brain regions, suggesting that its pathological impact is systemic rather than purely local. Remote brain dysfunction after SCI is unlikely to be driven by a single pathway, but may arise from the combined effects of systemic inflammation, autonomic imbalance, neuroendocrine dysregulation, and disruption of intestinal homeostasis. Unlike previous reviews that mainly discuss SCI-associated gut dysbiosis, neuroinflammation, or gut-brain communication separately, this review organizes SCI-related intestinal abnormalities around the concept of "gut-derived pathological signals" and further distinguishes direct SCI evidence from cross-disease mechanistic evidence and proposed mechanistic inference. Specifically, we summarize how intestinal dysmotility, microbial metabolic remodeling, abnormalities in short-chain fatty acids (SCFAs), barrier vulnerability, and mucosal immune imbalance after SCI may generate persistent pathological signals. We then analyze how these signals may affect the central nervous system through an immune-inflammatory main axis, a vagal neural relay branch, and a neuroendocrine modulatory branch, ultimately converging on a common downstream brain effector stage characterized by blood-brain barrier impairment, neuroinflammation, synaptic plasticity deficits, and dysfunction of key brain regions such as the hippocampus and medial prefrontal cortex (mPFC). Based on this cascade, we propose a stratified intervention framework involving upstream restoration of intestinal homeostasis, midstream regulation of interorgan transmission pathways, and downstream protection of brain effector mechanisms. Overall, this review provides an evidence-stratified gut-brain axis framework for understanding remote brain dysfunction after SCI and highlights the need for SCI-specific temporal mapping and pathway-selective causal validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.